Shaff Eric D. — SEC insider filings

SEC reporting owner CIK 1643734. 24 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2021-02-08 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Seres Therapeutics, Inc. (MCRB)Director20—14 legs · 50,755 sh · $60,83451
Sigilon Therapeutics, Inc. (SGTX)Director4——5

Insider filings — Shaff Eric D.

FiledFormIssuerReported transactionsSource
2026-11-174Seres Therapeutics, Inc. (MCRB)Option exercise (M): 724 · Sale (S): 287 @ $1.38 · Option exercise (M): 391 (derivative) @ $0 · Option exercise (M): 333 (derivative) @ $0EDGAR
2026-08-184Seres Therapeutics, Inc. (MCRB)Option exercise (M): 722 · Sale (S): 263 @ $4.55 · Option exercise (M): 390 (derivative) @ $0 · Option exercise (M): 332 (derivative) @ $0EDGAR
2026-07-104Seres Therapeutics, Inc. (MCRB)Grant/award (A): 6,500 (derivative) @ $0EDGAR
2026-05-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 722 · Sale (S): 259 @ $7.53 · Option exercise (M): 391 (derivative) @ $0 · Option exercise (M): 331 (derivative) @ $0EDGAR
2026-02-184Seres Therapeutics, Inc. (MCRB)Option exercise (M): 723 · Sale (S): 259 @ $8.47 · Option exercise (M): 391 (derivative) @ $0 · Option exercise (M): 333 (derivative) @ $0EDGAR
2025-11-184Seres Therapeutics, Inc. (MCRB)Option exercise (M): 390 · Option exercise (M): 331 · Sale (S): 217 @ $17.30 · Option exercise (M): 390 (derivative) @ $0 · Option exercise (M): 331 (derivative) @ $0EDGAR
2025-08-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 391 · Option exercise (M): 333 · Sale (S): 217 @ $16.65 · Option exercise (M): 391 (derivative) @ $0 · Option exercise (M): 333 (derivative) @ $0EDGAR
2025-05-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 390 · Option exercise (M): 331 · Sale (S): 220 @ $7.28 · Option exercise (M): 390 (derivative) @ $0 · Option exercise (M): 331 (derivative) @ $0EDGAR
2025-02-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 7,813 · Option exercise (M): 26,563 · Sale (S): 12,726 @ $0.81 · Option exercise (M): 7,813 (derivative) @ $0 · Option exercise (M): 26,563 (derivative) @ $0EDGAR
2025-02-114Seres Therapeutics, Inc. (MCRB)Grant/award (A): 1,950,000 (derivative) @ $0EDGAR
2024-11-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 7,812 · Sale (S): 2,505 @ $0.54 · Option exercise (M): 7,812 (derivative) @ $0EDGAR
2024-10-294Seres Therapeutics, Inc. (MCRB)Option exercise (M): 27,837 @ $0 · Sale (S): 8,748 @ $0.69 · Option exercise (M): 27,837 (derivative) @ $0EDGAR
2024-08-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 7,813 · Sale (S): 2,518 @ $0.84 · Option exercise (M): 7,813 (derivative) @ $0EDGAR
2024-05-174Seres Therapeutics, Inc. (MCRB)Option exercise (M): 7,812 · Sale (S): 2,435 @ $0.94 · Option exercise (M): 7,812 (derivative) @ $0EDGAR
2024-02-164Seres Therapeutics, Inc. (MCRB)Option exercise (M): 31,250 · Sale (S): 11,549 @ $1.08 · Grant/award (A): 637,500 (derivative) @ $0 · Grant/award (A): 822,580 (derivative) @ $0 · Grant/award (A): 106,250 (derivative) @ $0 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2023-10-314Seres Therapeutics, Inc. (MCRB)Option exercise (M): 27,838 @ $0 · Sale (S): 8,552 @ $1.35 · Grant/award (A): 55,675 (derivative) @ $0 · Option exercise (M): 27,838 (derivative) @ $0EDGAR
2023-08-114Sigilon Therapeutics, Inc. (SGTX)Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00EDGAR
2023-05-224Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $0EDGAR
2023-02-074Seres Therapeutics, Inc. (MCRB)Grant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2022-07-064Seres Therapeutics, Inc. (MCRB)Grant/award (A): 63,492 @ $3.15EDGAR
2022-05-274Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $0EDGAR
2022-02-084Seres Therapeutics, Inc. (MCRB)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2021-06-284Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $9.97EDGAR
2021-02-084Seres Therapeutics, Inc. (MCRB)Grant/award (A): 350,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643734 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs